The aim of the study was to determine whether there is any justification for measuring NE, S100B, and NSE in patients with T2DM and NfT2DM who have recovered from COVID-19, suggesting that these proteins might play a role in building a predictive model for PCS. The gene discussed is S100B; the disease is COVID-19.